These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 8711414)
1. Cholesterol and atherosclerotic vascular disease: from science to public health policy. Fröhlich J Sb Lek; 1996; 97(1):17-23. PubMed ID: 8711414 [TBL] [Abstract][Full Text] [Related]
2. Pathophysiology of coronary heart disease: a brief review. Chilton RJ J Am Osteopath Assoc; 2004 Sep; 104(9 Suppl 7):S5-8. PubMed ID: 15467017 [TBL] [Abstract][Full Text] [Related]
3. Use of statin drugs in women. LaRosa JC J Hypertens Suppl; 2002 May; 20(2):S70-2. PubMed ID: 12183858 [TBL] [Abstract][Full Text] [Related]
4. [Historical development of the cholesterol-atherosclerosis concept]. Epstein FH Ther Umsch; 1990 Jun; 47(6):435-42. PubMed ID: 2197752 [TBL] [Abstract][Full Text] [Related]
5. Lipid management in patients with vascular disease. Kohlman-Trigoboff D J Vasc Nurs; 2005 Jun; 23(2):72-6. PubMed ID: 16102476 [TBL] [Abstract][Full Text] [Related]
6. Interactions between the renin-angiotensin system and dyslipidemia: relevance in atherogenesis and therapy of coronary heart disease. Singh BK; Mehta JL Indian Heart J; 2001; 53(4):511-8. PubMed ID: 11759948 [TBL] [Abstract][Full Text] [Related]
8. Clinically integrated studies in pathology: their contribution to atherosclerosis research. Scott PJ Pediatr Pathol Mol Med; 2002; 21(3):239-57. PubMed ID: 12056501 [TBL] [Abstract][Full Text] [Related]
9. Pathogenic mechanisms of atherosclerosis: effect of lipid lowering on the biology of atherosclerosis. Ganz P; Creager MA; Fang JC; McConnell MV; Lee RT; Libby P; Selwyn AP Am J Med; 1996 Oct; 101(4A):4A10S-16S. PubMed ID: 8900332 [TBL] [Abstract][Full Text] [Related]
11. Coronary heart disease, hypercholesterolemia, and atherosclerosis. I. False premises. Stehbens WE Exp Mol Pathol; 2001 Apr; 70(2):103-19. PubMed ID: 11263954 [TBL] [Abstract][Full Text] [Related]
12. Is it wise to restrict fat in the diets of children? Olson RE J Am Diet Assoc; 2000 Jan; 100(1):28-32. PubMed ID: 10645998 [TBL] [Abstract][Full Text] [Related]
14. Cholesterol and atheroma lipids activate complement and stimulate granulocytes. A possible mechanism for amplification of ischemic injury in atherosclerotic states. Hammerschmidt DE; Greenberg CS; Yamada O; Craddock PR; Jacob HS J Lab Clin Med; 1981 Jul; 98(1):68-77. PubMed ID: 6265570 [TBL] [Abstract][Full Text] [Related]
15. Exercise and atherogenesis: where is the missing link? Gabriel HH; Heine G; Kröger K; Rätz M; Lichtenstern C; Schmitz A; Kindermann W Exerc Immunol Rev; 1999; 5():96-102. PubMed ID: 10519064 [TBL] [Abstract][Full Text] [Related]
16. The use of antioxidants in retarding atherosclerosis: fact or fiction? Futterman LG; Lemberg L Am J Crit Care; 1999 Mar; 8(2):130-3. PubMed ID: 10071704 [TBL] [Abstract][Full Text] [Related]
18. The epidemiology of coronary heart disease: a review. Richard JL Eff Health Care; 1985; 2(5):197-209. PubMed ID: 10300103 [TBL] [Abstract][Full Text] [Related]
19. Trends in plasma cholesterol levels in the atherosclerosis risk in communities (ARIC) study. Szklo M; Chambless LE; Folsom AR; Gotto A; Nieto FJ; Patsch W; Shimakawa T; Sorlie P; Wijnberg L Prev Med; 2000 Mar; 30(3):252-9. PubMed ID: 10684749 [TBL] [Abstract][Full Text] [Related]
20. [Prevention and therapy of vascular damage and endothelial dysfunction with hypocholesteremic agents]. De Caterina R; Lenzi S G Ital Cardiol; 1998 Feb; 28(2):168-77. PubMed ID: 9534058 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]